SEC Form 4 · accession 0001209191-15-024202
NOVAVAX INC · NVAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stanley C Erck
Officer — CEO and President · Director
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000694
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F1,F2 | $8.94 | Mar 5, 2015 | A | 900,000 | A | — | Mar 5, 2025 | Common Stock | 900,000 | 900,000 | D |
Explanation of responses
- F1This option grant was approved by a committee of Novavax's board of directors on March 5, 2015, subject to shareholder approval of the Novavax, Inc. 2015 Stock Incentive Plan.
- F2The option vests in four equal annual installments beginning on the first anniversary of the date of grant.